Cancer medicines

Durvalumab

Durvalumab

An immunotherapy used in selected lung and biliary tract cancers and other settings.

Sources checked · Introductory guide

On this page

How it works

It blocks PD-L1 to help the immune system attack cancer cells.[2]

Where it is used

Use in lung cancer depends on stage and prior treatment; in advanced biliary tract cancer it is combined with specific chemotherapy.[1]

Key safety points

Report new cough, breathlessness, diarrhea or jaundice immediately. Discuss autoimmune disease and prior chest radiation before treatment.[2]

Questions for your care team

  • What is its role at this treatment stage, and which symptoms should I watch for?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Durvalumab (opens in a new tab)
  2. MedlinePlus · Durvalumab (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Durvalumab | Cancer Encyclopedia | My Chemo Diary